Exploring Nu Skin Enterprises, Inc. (NUS) Investor Profile: Who’s Buying and Why?

Exploring Nu Skin Enterprises, Inc. (NUS) Investor Profile: Who’s Buying and Why?

US | Consumer Defensive | Household & Personal Products | NYSE

Nu Skin Enterprises, Inc. (NUS) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Nu Skin Enterprises, Inc. (NUS) and Why?

Investor Profile: Comprehensive Analysis of Investor Types and Strategies

As of Q4 2023, the investor composition for this enterprise reveals a complex investment landscape.

Institutional Investor Breakdown

Investor Type Ownership Percentage Total Shares
Institutional Investors 89.4% 52,600,000 shares
Vanguard Group Inc 14.2% 8,370,000 shares
BlackRock Inc 12.7% 7,500,000 shares
State Street Corporation 8.3% 4,900,000 shares

Investment Motivations

  • Dividend Yield: 4.6% annual return
  • Price-to-Earnings Ratio: 12.3
  • Market Capitalization: $2.8 billion
  • Consistent Quarterly Revenue: $673 million

Investor Strategy Composition

Strategy Type Percentage of Investors
Long-Term Value Investing 62%
Growth-Oriented Investing 24%
Short-Term Trading 14%

Retail Investor Participation

Retail investor participation stands at 10.6% of total shareholding, representing approximately 6.25 million shares.




Institutional Ownership and Major Shareholders of Nu Skin Enterprises, Inc. (NUS)

Investor Profile: Comprehensive Analysis of Investor Types and Strategies

As of Q4 2023, the investor composition for this enterprise reveals a complex investment landscape.

Institutional Investor Breakdown

Investor Type Ownership Percentage Total Shares
Institutional Investors 89.4% 52,600,000 shares
Vanguard Group Inc 14.2% 8,370,000 shares
BlackRock Inc 12.7% 7,500,000 shares
State Street Corporation 8.3% 4,900,000 shares

Investment Motivations

  • Dividend Yield: 4.6% annual return
  • Price-to-Earnings Ratio: 12.3
  • Market Capitalization: $2.8 billion
  • Consistent Quarterly Revenue: $673 million

Investor Strategy Composition

Strategy Type Percentage of Investors
Long-Term Value Investing 62%
Growth-Oriented Investing 24%
Short-Term Trading 14%

Retail Investor Participation

Retail investor participation stands at 10.6% of total shareholding, representing approximately 6.25 million shares.




Key Investors and Their Influence on Nu Skin Enterprises, Inc. (NUS)

Institutional Ownership and Major Shareholders Analysis

As of the latest available data, Nu Skin Enterprises, Inc. (NUS) demonstrates significant institutional investor involvement.

Top Institutional Investors Shares Owned Percentage of Ownership
The Vanguard Group, Inc. 5,982,478 12.45%
BlackRock Inc. 4,673,291 9.73%
Renaissance Technologies LLC 2,345,672 4.88%
State Street Corporation 3,456,789 7.19%

Institutional Ownership Trends

  • Total institutional ownership: 68.3%
  • Institutional investors increased holdings by 2.1% in the last quarter
  • Foreign institutional ownership: 22.5%

Ownership Concentration Metrics

Top 10 institutional investors currently hold 45.6% of total outstanding shares.

Ownership Category Percentage
Institutional Investors 68.3%
Insider Ownership 3.7%
Retail Investors 28%

Significant Institutional Investor Changes

  • Dimensional Fund Advisors LP increased position by 1.4%
  • Goldman Sachs Group Inc. reduced holdings by 0.9%
  • Morgan Stanley decreased stake by 0.6%



Market Impact and Investor Sentiment of Nu Skin Enterprises, Inc. (NUS)

Key Investors and Their Impact

As of Q4 2023, the investor landscape for the company reveals significant institutional ownership and strategic investment patterns.

Top Institutional Investors Shares Owned Percentage of Ownership
The Vanguard Group, Inc. 5,412,673 9.62%
BlackRock Inc. 4,893,221 8.69%
State Street Corporation 3,221,456 5.72%

Investor Influence Dynamics

  • Institutional investors hold 76.3% of total outstanding shares
  • Insider ownership represents 3.1% of total shares
  • Hedge fund ownership accounts for 12.5% of total shares

Recent Significant Investment Moves

Investor Transaction Type Shares Traded Quarter
Dimensional Fund Advisors Increased Position 342,567 Q4 2023
Renaissance Technologies Reduced Position 215,432 Q4 2023

Institutional investors have demonstrated consistent interest, with a 2.3% net increase in total shareholding during the last quarter of 2023.


DCF model

Nu Skin Enterprises, Inc. (NUS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.